Insights

COVID-19 Testing Services Orig3n's Emergency Use Authorization for COVID-19 tests presents a promising opportunity to offer testing services to nursing homes, boarding schools, clinicians, and underserved communities nationwide.

Partnerships for Test Solutions Collaborations with entities like CMS showcase the potential to develop tailored testing processes and strategies for large groups, indicating an opportunity for partnership-driven sales.

Healthcare Industry Solutions The launch of solutions for COVID-19 testing in healthcare facilities such as nursing homes signifies a sales opportunity to provide comprehensive testing services to similar establishments.

Pipeline Development and Therapies Orig3n's research team's focus on developing therapies using cutting-edge cellular science implies a potential for future collaborations on new treatment options, offering sales opportunities in healthcare innovation.

Genetic Testing Partnerships Strategic partnerships to offer genetic tests like the Vitamins test present an opportunity to work with other companies in the wellness and health sector, expanding sales reach and product offerings.

Orig3n Tech Stack

Orig3n uses 8 technology products and services including Google Hosted Libraries, WordPress, RequireJS, and more. Explore Orig3n's tech stack below.

  • Google Hosted Libraries
    Content Delivery Network
  • WordPress
    Content Management System
  • RequireJS
    Javascript Frameworks
  • YUI
    Javascript Libraries
  • Lightbox
    Javascript Libraries
  • Ubuntu
    Operating Systems
  • reCAPTCHA
    Security
  • Twitter
    Widgets

Media & News

Orig3n's Email Address Formats

Orig3n uses at least 1 format(s):
Orig3n Email FormatsExamplePercentage
first.last@orig3n.comJohn.Doe@orig3n.com
80%
first@orig3n.comJohn@orig3n.com
14%
last@orig3n.comDoe@orig3n.com
4%
middle@orig3n.comMichael@orig3n.com
2%

Frequently Asked Questions

Where is Orig3n's headquarters located?

Minus sign iconPlus sign icon
Orig3n's main headquarters is located at 27 Drydock Ave Boston, MA 02210 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Orig3n's phone number?

Minus sign iconPlus sign icon
You can contact Orig3n's main corporate office by phone at +1-800-316-7301. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orig3n's official website and social media links?

Minus sign iconPlus sign icon
Orig3n's official website is orig3n.com and has social profiles on LinkedIn.

What is Orig3n's SIC code NAICS code?

Minus sign iconPlus sign icon
Orig3n's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orig3n have currently?

Minus sign iconPlus sign icon
As of September 2021, Orig3n has approximately 13 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: R. S.Executive Assistant To Founder & CEO: M. S. J.Director Of Engineering: B. H.. Explore Orig3n's employee directory with LeadIQ.

What industry does Orig3n belong to?

Minus sign iconPlus sign icon
Orig3n operates in the Biotechnology Research industry.

What technology does Orig3n use?

Minus sign iconPlus sign icon
Orig3n's tech stack includes Google Hosted LibrariesWordPressRequireJSYUILightboxUbuntureCAPTCHATwitter.

What is Orig3n's email format?

Minus sign iconPlus sign icon
Orig3n's email format typically follows the pattern of . Find more Orig3n email formats with LeadIQ.

How much funding has Orig3n raised to date?

Minus sign iconPlus sign icon
As of September 2021, Orig3n has raised $126M in funding. The last funding round occurred on Jan 01, 2014 for $26M.

When was Orig3n founded?

Minus sign iconPlus sign icon
Orig3n was founded in 2014.
Orig3n

Orig3n

Biotechnology ResearchMassachusetts, United States11-50 Employees

Orig3n received Emergency Use Authorization clearance for their COVID-19 test on April 10, 2020. In addition to continuing work to provide the world with more knowledge about themselves based on their DNA, Orig3n is providing much needed COVID-19 capacity to nursing homes, boarding schools, clinicians, and underserved communities across the country.

Orig3n helps people understand the links between their genes and how their minds and bodies work. From fitness to nutrition to personality, our DNA tests provide easy, affordable access to genetic information and guidance on how to use it. We help people take charge of their health with the knowledge they need to make more informed choices.

Founded in 2014, Boston based Orig3n exists at the intersection of biological science and emerging technology. Through our DNA tests and community events, we help people understand the links between their genes and how their minds and bodies work. Our research team uses cutting-edge cellular science to develop personalized therapies for repairing tissue damage and disease. Together with our community, we’re on a mission to accelerate the future of regenerative medicine. 

Find out more at orig3n.com.

Section iconCompany Overview

Headquarters
27 Drydock Ave Boston, MA 02210 US
Phone number
+1-800-316-7301
Website
orig3n.com
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $126M

    Orig3n has raised a total of $126M of funding over 4 rounds. Their latest funding round was raised on Jan 01, 2014 in the amount of $26Mas a funding round.

Section iconFunding & Financials

  • $126M

    Orig3n has raised a total of $126M of funding over 4 rounds. Their latest funding round was raised on Jan 01, 2014 in the amount of $26Mas a funding round.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.